Summit Therapeutics (SMMT) News Today $26.13 +2.89 (+12.44%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Norges Bank Invests $1.78 Million in Summit Therapeutics Inc. (NASDAQ:SMMT)Norges Bank purchased a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 100,000 shares of the company's stock, valued at approximately $1,784,000. SeverApril 14 at 3:31 AM | marketbeat.com3 Magnificent Stocks That Could Double or More by 2030April 12 at 2:45 PM | fool.comWhy Summit Therapeutics Inc. (SMMT) Surged On Friday?April 12 at 3:26 AM | msn.comInvestors Purchase Large Volume of Summit Therapeutics Call Options (NASDAQ:SMMT)April 11 at 1:15 AM | americanbankingnews.comSummit co-CEO option exercise ‘quite bullish,’ says Cantor FitzgeraldApril 11 at 12:28 AM | markets.businessinsider.comSummit Therapeutics (SMMT) Gets a Buy from Truist FinancialApril 11 at 12:28 AM | markets.businessinsider.comWhy Summit Therapeutics Rallied Double Digits Today on Another Down day for the MarketsApril 10, 2025 | fool.comPolymer Capital Management HK LTD Invests $3.92 Million in Summit Therapeutics Inc. (NASDAQ:SMMT)Polymer Capital Management HK LTD acquired a new position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 219,820 shares of tApril 8, 2025 | marketbeat.comHeadlands Technologies LLC Invests $306,000 in Summit Therapeutics Inc. (NASDAQ:SMMT)Headlands Technologies LLC purchased a new stake in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 17,170 shares of the company's stock, valued at approximately $306,000. Several otApril 7, 2025 | marketbeat.comSummit Therapeutics Inc. (NASDAQ:SMMT) Shares Bought by Vanguard Group Inc.Vanguard Group Inc. grew its holdings in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 6.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,670,576 shares of the company's stock after purchApril 7, 2025 | marketbeat.com2 Stocks That Have More Than Doubled in the Past Year to Buy and Hold for a DecadeApril 6, 2025 | fool.comCinctive Capital Management LP Buys Shares of 27,270 Summit Therapeutics Inc. (NASDAQ:SMMT)Cinctive Capital Management LP purchased a new position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 27,270 shares of the company's stock,April 6, 2025 | marketbeat.comWe Think Summit Therapeutics (NASDAQ:SMMT) Can Easily Afford To Drive Business GrowthApril 5, 2025 | uk.finance.yahoo.comSummit Therapeutics (NASDAQ:SMMT) Trading 7% Higher - Should You Buy?Summit Therapeutics (NASDAQ:SMMT) Trading 7% Higher - Here's What HappenedApril 4, 2025 | marketbeat.com3 Growth Stocks That Have Dwarfed Nvidia's Returns Over the Past 12 MonthsApril 3, 2025 | fool.comPictet Asset Management Holding SA Increases Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT)Pictet Asset Management Holding SA boosted its position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 100.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,387,247 shares of the compApril 2, 2025 | marketbeat.comS&P 500 Futures Fall in Premarket Trading; Axsome Therapeutics, First Horizon LagApril 1, 2025 | marketwatch.comNEOS Investment Management LLC Makes New $475,000 Investment in Summit Therapeutics Inc. (NASDAQ:SMMT)NEOS Investment Management LLC bought a new stake in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 26,641 shares of the company's stock, valuedApril 1, 2025 | marketbeat.comWhy Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged TodayMarch 31, 2025 | fool.comWant $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.March 31, 2025 | fool.com94,760 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Purchased by Artisan Partners Limited PartnershipArtisan Partners Limited Partnership acquired a new position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 94,760 shares of the company's stock,March 31, 2025 | marketbeat.comCitigroup Upgrades Summit Therapeutics (BMV:SMMT)March 28, 2025 | nasdaq.comCitigroup Upgrades Summit Therapeutics (SMMT)March 27, 2025 | msn.comSummit Therapeutics (NASDAQ:SMMT) Shares Gap Up - Time to Buy?Summit Therapeutics (NASDAQ:SMMT) Shares Gap Up - Still a Buy?March 27, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Upgraded at CitigroupCitigroup raised shares of Summit Therapeutics from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $23.00 to $35.00 in a research note on Wednesday.March 27, 2025 | marketbeat.comWhy Summit Therapeutics Stock Slipped TodayMarch 26, 2025 | fool.comSummit Therapeutics upgraded ahead of lung cancer trial data readoutMarch 26, 2025 | proactiveinvestors.comS&P 500 Futures Decline in Premarket Trading; GameStop, Summit Therapeutics LeadMarch 26, 2025 | marketwatch.comIvyRock Asset Management HK Ltd Invests $2.97 Million in Summit Therapeutics Inc. (NASDAQ:SMMT)IvyRock Asset Management HK Ltd bought a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 166,500 shares of the company's stock, valueMarch 26, 2025 | marketbeat.comVirtu Financial LLC Sells 15,365 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT)Virtu Financial LLC trimmed its holdings in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 36.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 26,878 shares of the company's stock after sellMarch 26, 2025 | marketbeat.comAnalyst Initiates Coverage On 'Undervalued' Summit TherapeuticsMarch 24, 2025 | benzinga.comIs Summit Therapeutics a Millionaire Maker?March 23, 2025 | fool.comSummit Therapeutics (NASDAQ:SMMT) Now Covered by Analysts at Cantor FitzgeraldCantor Fitzgerald began coverage on shares of Summit Therapeutics in a research report on Friday. They set an "overweight" rating on the stock.March 22, 2025 | marketbeat.comSummit Therapeutics Inc. (NASDAQ:SMMT) Given Average Recommendation of "Moderate Buy" by BrokeragesSummit Therapeutics Inc. (NASDAQ:SMMT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the nine ratings firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and eight have givenMarch 22, 2025 | marketbeat.comSummit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 21, 2025 | businesswire.comSummit Therapeutics initiated with an Overweight at Cantor FitzgeraldMarch 21, 2025 | markets.businessinsider.comSummit Therapeutics (SMMT) Gets a Buy from Cantor FitzgeraldMarch 21, 2025 | markets.businessinsider.comThis Unstoppable Biotech Stock Just Became an Even Better BuyMarch 19, 2025 | msn.comSkandinaviska Enskilda Banken AB publ Takes Position in Summit Therapeutics Inc. (NASDAQ:SMMT)Skandinaviska Enskilda Banken AB publ bought a new position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 32,663 shares of the company's stock, valued at approximately $586,000. Several other hedgMarch 18, 2025 | marketbeat.comSummit Therapeutics Inc. (NASDAQ:SMMT) Shares Purchased by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. lifted its stake in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 3.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,485,072 shares of the company's stocMarch 18, 2025 | marketbeat.comRobert LaCaze, Innovative Growth-Driver in Oncology, Joins Summit Therapeutics as Chief Commercial OfficerMarch 17, 2025 | businesswire.comBank of New York Mellon Corp Has $5.95 Million Stock Position in Summit Therapeutics Inc. (NASDAQ:SMMT)Bank of New York Mellon Corp lifted its holdings in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 33.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 333,510 shares of the company's stMarch 17, 2025 | marketbeat.comSummit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 14, 2025 | businesswire.comWhy Summit Therapeutics Stock Was Winning This WeekMarch 14, 2025 | fool.comIs Summit Therapeutics Inc. (SMMT) the Best Multibagger Stock to Buy in 2025?March 13, 2025 | insidermonkey.comSummit Therapeutics (NASDAQ:SMMT) Stock Price Up 9.5% - Here's What HappenedSummit Therapeutics (NASDAQ:SMMT) Shares Up 9.5% - Should You Buy?March 13, 2025 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Coverage Initiated at Evercore ISIEvercore ISI started coverage on shares of Summit Therapeutics in a report on Wednesday. They issued an "outperform" rating and a $30.00 target price on the stock.March 13, 2025 | marketbeat.comThis Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This YearMarch 13, 2025 | fool.comSummit Therapeutics Inc. (SMMT): Why Are Analysts Bullish On This Hot Growth Stock Right Now?March 8, 2025 | msn.comSummit Therapeutics (NASDAQ:SMMT) Shares Down 5.7% - Should You Sell?Summit Therapeutics (NASDAQ:SMMT) Stock Price Down 5.7% - Here's What HappenedMarch 8, 2025 | marketbeat.com Remove Ads Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address SMMT Media Mentions By Week SMMT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SMMT News Sentiment▼0.980.86▲Average Medical News Sentiment SMMT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SMMT Articles This Week▼106▲SMMT Articles Average Week Remove Ads Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today argenx News Today Beigene News Today BioNTech News Today Teva Pharmaceutical Industries News Today Intra-Cellular Therapies News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Moderna News Today Viatris News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SMMT) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SMMT Stock Free SMMT Stock Alerts